Advanced Cell Technology Awarded Broad Patent for Production of Retinal Pigment Epithelial Cells
Key Patent Covers Fundamental Methods for Producing RPE Cells from Embryonic Stem Cells Including IP Used in Phase I Trial to Treat Patients with Stargardt's Macular Dystrophy.
View full press release